APLM Apollomics highlights oncology pipeline progress and upcoming clinical trial milestones in its latest quarterly earnings report XHG XChange reports narrower than expected Q4 2019 loss shares rise 392 percent on upbeat investor sentiment Is Tapestry TPR stock positioned for growth Q1 2026 EPS Tops Views